Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![raghavwadhwa Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::100281231.png) Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97.1K followers
Created: 2025-07-17 09:09:32 UTC

🔹Eli Lilly launched tirzepatide (Mounjaro) in India, expanding therapeutic options with a dual GIP/GLP-1 receptor agonist.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945772846833455577/c:line.svg)

**Related Topics**
[india](/topic/india)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/raghavwadhwa/status/1945772846833455577)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

raghavwadhwa Avatar Raghav Wadhwa @raghavwadhwa on x 97.1K followers Created: 2025-07-17 09:09:32 UTC

🔹Eli Lilly launched tirzepatide (Mounjaro) in India, expanding therapeutic options with a dual GIP/GLP-1 receptor agonist.

XXXXX engagements

Engagements Line Chart

Related Topics india eli lilly stocks healthcare

Post Link

post/tweet::1945772846833455577
/post/tweet::1945772846833455577